european psychiatric association

EPA joins Sleep Health Europe Coalition

The EPA is pleased to announce that it has joined the Sleep Health Europe Coalition. The Coalition gathers voices and associations from across sleep science, healthcare, advocacy, and civil society. The EPA is proud to represent the psychiatry community as part…

Posted by - Policy & Advocacy -

Parliamentary Assembly of the Council of Europe unanimously rejects protocol on involuntary measures in mental health

The Parliamentary Assembly of the Council of Europe (PACE) has unanimously adopted an opinion opposing the draft additional protocol on involuntary placement and treatment in mental healthcare services to the Convention on Human Rights and Biomedicine (Oviedo Convention) on 28…

Posted by - Policy & Advocacy -

Parliamentary Assembly of the Council of Europe votes to prohibit Conversion “Therapies”

The EPA  welcomes the recent vote by the Parliamentary Assembly of the Council of Europe (PACE) calling on European countries to adopt legislation prohibiting conversion practices. Adopted by a clear majority during the Assembly’s plenary session in Strasbourg, the resolution…

Posted by - Policy & Advocacy -

EPA speaks on Digital Violence and Women’s Mental Health at the European Parliament

The European Parliament’s Committee on Women’s Rights and Gender Equality (FEMM) and Committee on Public Health (SANT) have held a joint Hearing on “Digital violence and women’s mental health”, on Thursday, 11 December 2025. The hearing featured a presentation by…

EPA presents Headway Report on Mental Health at the European Parliament

Prof. Andrea Fiorillo, EPA President, and Prof. Celso Arango, EPA President Elect presented the latest edition of the Headway – Mental Health Index 5.0 on “Care, Cohesion, and Growth: Advancing Mental Health through the Wellbeing Economy” at the European Parliament…

First Patient Included Marks Major Milestone in EU-Funded Clinical Trial

Fantastic news! PsyPal has reached a major milestone with the inclusion of its first patient in the multi-site clinical trial investigating psilocybin therapy for psychological and existential distress in people with progressive, life-limiting illnesses. The EPA is proud to be…

Posted by - Policy & Advocacy -

EPA continues membership of EMA Healthcare Professionals Working Party

The EPA is pleased to announce its continued membership of the European Medicines Agency (EMA) Healthcare Professionals Working Party (HCPWP) for the 2025–2028 mandate. Established in 2013, the HCPWP brings together a wide range of healthcare professional organisations to provide…

Posted by - Policy & Advocacy -

EPA participates at the Mental Health Summit in the European Parliament

Mental Health Summit: Prevention and Recovery in Modern Society European Parliament, Brussels | 19 – 20 MAY 2025 On the occasion of Mental Health Week, starting on 19 May 2025, MEP András Kulja, Vice Chair of ENVI, and SANT Vice Coordinator, together with MEP Zoltán Tarr,…

Posted by - Policy & Advocacy -

11th EPA Forum gathers Mental Health Community & Policymakers in Madrid

The 11th EPA Forum took place in Madrid on Saturday, 5 April 2025. The event gathered the EPA community, civil society partners, national ministries, and the EU institutions to share perspectives on mental health at work ahead of the 33rd European…

Psychiatrists, Psychologists, Carers, and Patient Associations from the Netherlands share Perspective for 2035

  The EPA is pleased to share the Perspective on a Mentally Healthier 2035, a joint initiative of MIND, the Dutch Association of Mental Health and Addiction Care (de Nederlandse GGZ), the Netherlands Institute of Psychologists (NIP) and the Netherlands…

Posted by - Policy & Advocacy - Research & Guidance -